-
Study aim
-
Determining the effect of probiotics on gastrointestinal symptoms in patients with gastric cancer
-
Design
-
Clinical trial with control group, with parallel groups, randomized
-
Settings and conduct
-
Sixty patients referred to the gastrointestinal clinic of the teaching hospitals of the Islamic Azad University of Mashhad, based on inclusion criteria, will be randomly assigned (blocking) to the intervention or control group without the knowledge in which group they are in. VAS visual scale for Gastrointestinal symptoms such as abdominal pain, diarrhea, constipation and bloating will complted for both group before and two months after the intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age between 18 to 70 years, Endoscopically confirmed gastric cancer and pathology that are in the recovery phase (their treatment is over), Refer to the gastroenterology clinic of Azad University of Mashhad Educational hospitals, Informed consent to enter the study. Exclusion criteria: Obvious neurological disease, Probiotic consumption in the past month, Dissatisfaction with inclusion in the study, Lack of cooperation, Lack of proper use of the Probiotic in both groups, Sensitivity to the studied Probiotic, Pregnant or lactating women, Chronic users of non-steroidal anti-inflammatory drugs.
-
Intervention groups
-
In the intervention group, probiotic capsules containing three strains of probiotic bacteria including Lactobacillus acidophilus, Bifidobacterium lactis and Bifidobacterium longum will be given to them and it is recommended to take one capsule daily in the first two weeks. In the control group, participants will receive capsules containing maltodextrin prepared in both color and shape of the product capsules.
-
Main outcome variables
-
VAS visual scale